Schizophrenia and diabetes: Epidemiological data

European Psychiatry

Volumn 20, Issue SUPPL. 4, 2005, Pages

  Rouillon, F ^a   Sorbara, F ^b,c  

^a CENTRE HOSPITALIER SAINTE ANNE   (France)

^b Lilly France   (France)

^c CENTRE HOSPITALIER CHARLES PERRENS   (France)

Author keywords

Diabetes; Epidemiological data; Schizophrenia

Indexed keywords

NEUROLEPTIC AGENT;

BIOLOGICAL MODEL; COMORBIDITY; CONFERENCE PAPER; CONGENITAL MALFORMATION; ENVIRONMENTAL FACTOR; HUMAN; NERVE CELL DIFFERENTIATION; NEUROENDOCRINE SYSTEM; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SCHIZOPHRENIA; SITTING;

ANTIPSYCHOTIC AGENTS; COMORBIDITY; DIABETES MELLITUS; DRUG THERAPY, COMBINATION; HUMANS; SCHIZOPHRENIA;

EID: 31944439791     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-9338(05)80189-0     Document Type: Conference Paper

References (26)

1. Alberti K.G. The clinical implications of impaired glucose tolerance Diab Med 13 11 1996 927 937
2. Andrews R.C.R. Diabetes and schizophrenia: genes or zinc deficiency Lancet 340 1992 1160
3. Braceland F.J., Meduna L.J., and Vaichulis J.A. Delayed reaction of insulin in schizophrenia Am J Psychiatry 102 1945 108 110
4. Brambilla F., Guastalla A., Guerrini A., Riggi F., Rovere C., and Zanoboni A. Glucose-insulin metabolism in chronic schizophrenia Dis Nerv Syst 37 2 1976 98 103
5. Bromel T., Blum W.F., Ziegler A., Schulz E., Bender M., and Fleischhaker C. Serum leptin levels increase rapidly after initiation of clozapine therapy Mol Psychiatry 3 1998 76 80
6. Bushe C., and Holt R. Prevalence of diabetes and impaired glucose tolerance in patients with schizophrenia Br J Psychiatry Suppl 47 2004 S67 S71
7. Casadebaig F., Philippe A., Guillaud-Bataille J.M., Gausset M.F., Quemada N., and Terra J.L. Schizophrenic patients: physical health and access to somatic care Eur Psychiatry 12 1997 289 293
8. Cheta D., Dumitrescu C., Georgescu M., Cocioaba G., Lichiardopol R., and Stamoran M. A study on the types of diabetes mellitus in first degree relatives of diabetic patients Diabete Metab 16 1 1990 11 15
9. Dixon L., Weiden P., Delahunty J., Goldberg R., Postrado L., and Lucksted A. Prevelance on correlates of diabetes in national schizophrenia samples Schizophr Bull 26 2000 903 912
10. Finney G.O.H. Juvenile onset diabetes and schizophrenia? Lancet 334 1989 1214 1215
11. Gupta S., Steinmeyer C., Frank B., Madhusoodanan S., Lockwood K., and Lentz B. Hyperglycemia and hypertriglyceridemia in real world patients on antipsychotic therapy Am J Ther 10 5 2003 348 355
12. Hagg S., Soderberg S., Ahren B., Olsson T., and Mjorndal T. Leptin concentrations are increased in subjects treated with clozapine or conventional antipsychotics J Clin Psychiatry 62 2001 843 848
13. Kasanin J. The blood sugar curve in mental disease: the schizophrenic (dementia praecox) groups Arch Neurol Psychiatry 16 1926 414 419
14. Kooy F.H. Hyperglycaemia in mental disorders Brain 42 1919 214 289
15. Lindenmayer J.P., Czobor P., Volavka J., Citrome L., Sheitman B., and McEvoy J.P. Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics Am J Psychiatry 1602 2003 290 296
16. Maudsley H. The pathology of mind. Second part of the physiology and pathology of the mind, recast/enlarged and rewritten Third edition 1879 Macmillan
17. McKee H.A., D'Arcy P.F., and Wilson P.J. Diabetes and schizophrenia-a preliminary study J Clin Hosp Pharm 11 1986 297 299
18. Mukherjee S., Decina P., Bocola V., Saraceni F., and Scapicchio P. Diabetes Mellitus in schizophrenic patients Comp Psychiatry 37 1996 68 73
19. Mukerjee S., Schur D.B., and Reddy R. Family history of type 2 diabetes in schizophrenic patients Lancet 333 1989 495
20. Regenold W.T., Thapar R.K., Marano C., Gavirneni S., and Kondapavuluru P.V. Increased prevalence of type 2 diabetes mellitus among psychiatric inpatients with bipolar I affective and schizoaffective disorders independent ofpsychotropic drug use J Affect Disord 70 2002 19 26
21. Ryan M.C.M., and Thakore J.H. Physical consequences of schizophrenia and its treatment: the metabolic syndrome Life Sci 71 2002 239 257
22. Ryan M.C., Collins P., and Thakore J.H. Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia Am J Psychiatry 160 2 2003 284 289
23. Sernyak M.J., Leslie D.L., Alarcon R.D., Losonczy M.F., and Rosenheck R. Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia Am J Psychiatry 159 2002 561 566
24. Subramaniam M., Chong S.A., and Pek E. Diabetes mellitus and impaired glucose tolerance in patients with schizophrenia Can J Psychiatry 48 5 2003 345 347
25. Thonnard-Neumann E. Phenothiazone and diabetes in hospitalised women Am J Psychiatry 29 1956 827 828
26. Thonnard-Neumann E. Phenothiazone and diabetes in hospitalised women Am J Psychiatry 124 1968 978 982